http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017304546-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9305fc720f87097494d965f1b1310e24
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2017-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6431db52b16458260421c8ca83b86680
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb3f09561cfa11518d37820a8c91cbe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1e6c2ed021c90d506fe4d6348fc789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9112cf46ef39b7b3b32e069783edc223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b8549adba1575efdc2ac0ae8709e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9754040e110a1100a3af104f2133062d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db19cc1894135a4da30be12fbc50196
publicationDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2017304546-B2
titleOfInvention Anticancer pharmaceutical composition
abstract The present invention provides a pharmaceutical composition for treating or preventing cancer, containing, as an active ingredient, a compound having a specific chemical structure and an activity of inhibiting the formation of a c-Myc/Max/DNA complex, or a pharmaceutically acceptable salt thereof. The present invention provides a medical use of the pharmaceutical composition, according to the present invention, for treating or preventing cancer. The present invention also provides a method for treating or preventing cancer, comprising administering, to a subject in need of treatment, an effective amount of the compound, the salt thereof, or the composition, according to the present invention, containing both the compound and the salt thereof.
priorityDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466307324

Total number of triples: 30.